Short answer · Medically reviewed summary · Last updated: 2026-04-06
Cystic Fibrosis was first formally characterized as a distinct clinical entity in 1938 by pathologist Dr. Dorothy Andersen, who identified the condition’s signature pancreatic and pulmonary manifestations during autopsies of children. From Folklore to Clinical Definition Before the 20th century, the history of Cystic Fibrosis was clouded by superstition; European folklore warned that "a child who tastes salty when kissed will soon die," a chillingly accurate observation of the high sweat-chloride levels characteristic of the disease.
3 people with Cystic Fibrosis have shared their first-person experience on this question at DiseaseMaps.
What is the history of Cystic Fibrosis?
History of Cystic Fibrosis: when and how it was discovered, and the milestones in research since, medically reviewed.
Cystic Fibrosis was first formally characterized as a distinct clinical entity in 1938 by pathologist Dr. Dorothy Andersen, who identified the condition’s signature pancreatic and pulmonary manifestations during autopsies of children.
From Folklore to Clinical Definition
Before the 20th century, the history of Cystic Fibrosis was clouded by superstition; European folklore warned that "a child who tastes salty when kissed will soon die," a chillingly accurate observation of the high sweat-chloride levels characteristic of the disease. It wasn't until 1938 that Dr. Andersen provided a scientific framework, naming it "cystic fibrosis of the pancreas" to describe the scarred, obstructed ducts she observed in her patients.
Evolution of Understanding and Treatment
The understanding of Cystic Fibrosis underwent a revolution in 1989 when researchers, including Dr. Francis Collins and Dr. Lap-Chee Tsui, identified the CFTR gene. This discovery transformed the condition from a mysterious, fatal childhood illness into a manageable genetic disorder. Previously, treatment was limited to palliative care and rudimentary chest physical therapy. Today, the development of CFTR modulators represents a major milestone, as these therapies address the underlying protein defect rather than just managing symptoms.
Advocacy and the Modern Era
The history of Cystic Fibrosis is also a story of patient resilience. In the mid-20th century, life expectancy was often measured in months. Through the tireless advocacy of organizations like the Cystic Fibrosis Foundation, established in 1955, the focus shifted toward aggressive airway clearance, specialized nutritional support, and groundbreaking genetic research. This advocacy has fostered a global community where, as seen here at DiseaseMaps, patients and families actively share experiences to improve clinical outcomes.
Medical Disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: The portal for rare diseases and orphan drugs
- Cystic Fibrosis Foundation: History and Milestones
- OMIM (Online Mendelian Inheritance in Man)
Posted Oct 2, 2017 by Andrew 1800
Posted Jan 18, 2018 by Marieliz Landa 4060
Posted Sep 14, 2017 by Glauco 2000
